Meeting Details

The 37th Annual General Meeting of Venus Remedies Limited was held on Thursday, 20th August 2026 at 11:30 am IST through Video Conferencing/Other Visual Audio Means (VC/OVAM) facility. The meeting was conducted in compliance with circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India.

Attendance

Total 59 members attended the meeting through VC/OVAM facility. The requisite quorum was present.

Board of Directors and Key Managerial Personnel Present

1. Mr. Ashutosh Jain - Executive Director

2. Mr. Akshansh Chaudhary - Executive Director

3. Saransh Chaudhary - Executive Director

4. Mr. NPS Monga - Independent Director and Chairman of Audit Committee

5. Dr. (Mrs.) Savita Gupta - Chairman of Stakeholder Relationship Committee

6. Mr. Navdeep Sud - Independent Director

7. Dr. Anil Kumar - Independent Director

8. Dr. Gurminder Singh Bedi - Independent Director

9. Mr. Prince Chadha - Secretarial Auditor and Scrutinizer

10. Mr. Anurag Verma - Statutory Auditor

11. Mrs. Neha Kodan - Company Secretary

12. Mr. Rakesh Pandit - Head-Corporate Secretarial

Voting Process

The company arranged for electronic voting through M/s. MUFG Intime India Pvt. Ltd. The e-voting period commenced on 17th August 2026 at 9:00 am IST and concluded on 19th August 2026 at 5:00 pm IST. Shareholders present at the AGM who hadn't participated in electronic voting were given an option to cast their votes electronically within the final 15 minutes after the conclusion of AGM proceedings.

Mr. Prince Chadha of M/s. P. Chadha & Associates was appointed as Scrutinizer to oversee the electronic voting process.

Resolutions Put to Vote

The following resolutions set out in the AGM notice were put to vote:

Ordinary Resolutions:

1. To receive, consider and adopt the audited standalone financial statements for the financial year ended 31st March 2026 and reports of Board of Directors and Auditor

2. To receive, consider and adopt the audited consolidated financial statements for the financial year ended 31st March 2026 and report of the Auditor

3. To declare final dividend of ₹10 (Rupees Ten only) per equity share (100% on face value of ₹10)

4. To re-appoint Mr. Ashutosh Jain (DIN: 01336895) as director liable to retire by rotation

5. To re-appoint Mr. Peeyush Jain (DIN: 00440361) as director liable to retire by rotation

6. To ratify remuneration of ₹1,10,000 per annum for cost auditors for financial year 2026-27

Special Resolutions:

7. To appoint Mr. Saransh Chaudhary as Executive Director (Whole Time Director) for a term of five years

8. To appoint Dr. Gurminder Singh as Non-Executive Independent Director for a term of five years

9. To re-appoint Dr. (Mrs.) Manu Chaudhary as Joint Managing Director for five years

10. To re-appoint Dr. (Mrs.) Savita Gupta as Non-Executive Independent Director for a second term of five years

11. To alter the Memorandum of Association

12. To adopt new Articles of Association

Chairman's Address

The Chairman presented an overview of the company's performance during Financial Year 2025-2026, highlighted key achievements since the previous AGM, and outlined the company's future outlook and growth prospects.

Question and Answer Session

Fourteen members had registered as speakers for the AGM. Seven members attended as speakers and raised queries:

1. Lavneesh Mohan from Blueocean Emerging India Fund 1

2. Shahi Jajn

3. Vishal Prasad

4. Deepali Singhal from Perpetuity Health to Wealth (H2W) Emerging Fund

5. Yashvee Kothari

6. Lalaram Sukhvir

7. Manprit Singh Aurora

The queries related to the company's financials, products, strategies, and future plans, which were responded to by Board members.

Meeting Conclusion

The AGM concluded at 01:13 pm IST, including time allowed for insta-poll at the AGM. Mr. NPS Monga presented the vote of thanks.

Post-Meeting Procedures

The combined result of e-voting and polling results will be declared within 48 hours of the conclusion of the meeting. The voting results pursuant to Regulation 44(3) of SEBI Listing Regulations and Report of the Scrutinizer pursuant to Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014 will be submitted in due course.